2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections

The present invention relates to new 2-piperazin-1-yl-4H-1,3-benzothiazin- 4-one derivatives and their use for the treatment of mammalian infections caused by bacteria, especially diseases like tuberculosis (TB), Buruli ulcer and leprosy that result from infection with closely related mycobacteria. (I).


Year:
2012
Other identifiers:
TTO: 6.1036
EPO Family ID: 45349249
Laboratories:




 Record created 2015-09-22, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)